External Therapy of TCM on Fatigue and Negative Emotion of COVID-19 Patients:a Randomized Controlled Trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200006039

Enrollment

Unknown

Registered

2022-05-26

Start date

2022-05-18

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatigue,negative emotion

Interventions

Control group:conventional care

Treatment group:external therapy of TCM

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Diagnosed with COVID-19; (2) BFI-C=4 ; (3) Willing to participate in the trial and provide written consent.

Exclusion criteria

Exclusion criteria: (1) Patients with multiple organ system failure; (2) Patients with dementia or mental illness can't communicate normally with others. (3) Acupuctured area with severe ulcers, abscesses, skin infections, etc. (4) Allergic to ingredients of Traditional Chinese medicine or adhesive; (5) Having participated in other clinic trials within the past 1 month.

Design outcomes

Primary

Measure	Time frame
Brief Fatigue Inventory;	—

Secondary

Measure	Time frame
Generalized Anxiety Disorder-7;PTSD Checklist-5;Patient Health Questionnaire-9;Sleep Dysfunction Rating Scale;	—

Countries

China

Contacts

Public ContactYang Zongguo

yangzongguo@shphc.org.cn18121157892

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026